Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral labetalol versus nifedipine for severe hypertension in pregnancy
PACTR202406618856160Completed
- Sponsor
- Eze Obinna
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in maternal hypertension (HDP) comparing Oral labetalol with Oral nifedipine retard (2 arms). Primary endpoint: Efficacy in optimal blood pressure control. Started Oct 2022; status: completed.
02
Drugs
labetalolnifedipine
03
Conditions
maternal hypertension (HDP)
Beyond the preview
Go deeper on PACTR202406618856160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202406618856160.